PMID- 32562382 OWN - NLM STAT- MEDLINE DCOM- 20210621 LR - 20210621 IS - 2055-5822 (Electronic) IS - 2055-5822 (Linking) VI - 7 IP - 5 DP - 2020 Oct TI - QRS fragmentation as a possible electrocardiographic diagnostic marker in patients with acute myocarditis: preliminary histopathological validation. PG - 2527-2533 LID - 10.1002/ehf2.12821 [doi] AB - AIMS: We aim to assess the reproducibility of QRS fragmentation (fQRS) on a multi-centre dataset of patients with acute myocarditis (AM), including a histopathological validation in a subgroup with biopsy-proven disease. Electrocardiogram (ECG) in patients with myocarditis is usually considered aspecific. ST changes and conduction anomalies have been commonly reported so far. We have previously described fQRS in patients with AM. METHODS AND RESULTS: Patients admitted between 2008 and 2019 in two centres with a diagnosis of AM were included. Standard ECG, echocardiography, and cardiac magnetic resonance (CMR) findings were recorded at baseline and at follow-up (FU). Eighty patients were analysed, 66 men (82%), with median age of 34 (26-43) years. Twenty-two patients had biopsy-proven AM. At presentation, 61 patients (76%) displayed fQRS. Median ejection fraction (EF) was 55% (43-60). Seventy-two patients (90%) underwent CMR and displayed late gadolinium enhancement (LGE). ECG leads showed that fQRS correlated with distribution of LGE. In patients with positive biopsy, fQRS was present in 18 (81%). Median FU was 419 days (224-956). Complete FU was available for 64 patients (80%), and 33 patients (52%) displayed persistence of fQRS. Median EF was 60% (57-64). Eleven patients underwent a repeated biopsy at FU, eight of whom had persistent inflammation and fQRS. Fifteen patients (23%) had ventricular tachycardia, 14 of whom still showed fQRS. CONCLUSIONS: In this cohort fQRS was confirmed as an additional useful ECG sign. Persistence of fQRS was associated with ongoing inflammation and with a poorer outcome in terms of ventricular function and occurrence of arrhythmias. CI - (c) 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology. FAU - Ferrero, Paolo AU - Ferrero P AUID- ORCID: 0000-0001-7967-7417 AD - Cardiovascular Department, Papa Giovanni XXIII Hospital, Bergamo, Italy. FAU - Piazza, Isabelle AU - Piazza I AUID- ORCID: 0000-0002-1316-8107 AD - Cardiovascular Department, Papa Giovanni XXIII Hospital, Bergamo, Italy. FAU - Kuhl, Uwe AU - Kuhl U AD - Department of Cardiology, University of Medicine Berlin, Charite, Campus Virchow Klinikum, Berlin, Germany. FAU - Grosu, Aurelia AU - Grosu A AD - Cardiovascular Department, Papa Giovanni XXIII Hospital, Bergamo, Italy. FAU - Tschope, Carsten AU - Tschope C AD - Department of Cardiology, University of Medicine Berlin, Charite, Campus Virchow Klinikum, Berlin, Germany. AD - DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany. AD - Berlin Institute of Health/Center for Regenerative Therapy (BCRT), Berlin, Germany. FAU - Senni, Michele AU - Senni M AD - Cardiovascular Department, Papa Giovanni XXIII Hospital, Bergamo, Italy. LA - eng PT - Journal Article DEP - 20200619 PL - England TA - ESC Heart Fail JT - ESC heart failure JID - 101669191 RN - 0 (Contrast Media) RN - AU0V1LM3JT (Gadolinium) SB - IM MH - Adult MH - Contrast Media MH - Electrocardiography MH - Gadolinium MH - Humans MH - Male MH - *Myocarditis/diagnosis/epidemiology MH - Reproducibility of Results PMC - PMC7524046 OTO - NOTNLM OT - Diagnosis OT - Myocarditis OT - QRS fragmentation COIS- None declared. EDAT- 2020/06/21 06:00 MHDA- 2021/06/22 06:00 PMCR- 2020/06/19 CRDT- 2020/06/21 06:00 PHST- 2020/03/10 00:00 [received] PHST- 2020/05/17 00:00 [revised] PHST- 2020/05/20 00:00 [accepted] PHST- 2020/06/21 06:00 [pubmed] PHST- 2021/06/22 06:00 [medline] PHST- 2020/06/21 06:00 [entrez] PHST- 2020/06/19 00:00 [pmc-release] AID - EHF212821 [pii] AID - 10.1002/ehf2.12821 [doi] PST - ppublish SO - ESC Heart Fail. 2020 Oct;7(5):2527-2533. doi: 10.1002/ehf2.12821. Epub 2020 Jun 19.